Related Experiment Video
Updated: Aug 15, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis
Hyun-Mi Ko1, Yeong-Min Park, Bongnam Jung
1Department of Biological Sciences, The Institute of Basic Sciences, Chonnam National University, Kwangju, Republic of Korea.
Abstract:
Platelet-activating factor (PAF) augments angiogenesis by promoting the synthesis of various angiogenic factors, via the activation of NF-kappaB. In this study, we investigated the role of the matrix metalloproteinase (MMP)-9, in PAF-induced angiogenesis. PAF increased mRNA expression, protein synthesis, and MMP-9 activity in ECV304 cells, in a NF-kappaB-dependent manner. PAF increased MMP-9 promoter activity in ECV304, which was inhibited by WEB2107, and NF-kappaB inhibitors. Transfected NF-kappaB subunits, p65 or/and p50, increased luciferase activity in the reporter plasmid MMP-9, resulting in an increase not only of MMP-9 luciferase activity, but also of mRNA expression in MMP-9. MMP-9 or NF-kappaB inhibitors significantly inhibited PAF-induced angiogenesis, in a dose-dependent manner, in an in vivo mouse Matrigel implantation model. In a parallel to the Matrigel implantation study, MMP-9 or NF-kappaB inhibitors inhibited PAF-induced sprouting of porcine pulmonary arterial endothelial cells. These data indicate that NF-kappaB-dependent MMP-9 plays a key role in PAF-induced angiogenesis.
Insights
Platelet-activating factor (PAF) drives angiogenesis by activating NF-kappaB, which increases matrix metalloproteinase-9 (MMP-9). Inhibiting MMP-9 or NF-kappaB blocks this PAF-induced angiogenesis, highlighting their key roles.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Platelet-activating factor (PAF) is known to promote angiogenesis.
- This process involves the activation of NF-kappaB and the synthesis of angiogenic factors.
Purpose of the Study:
- To investigate the role of matrix metalloproteinase-9 (MMP-9) in PAF-induced angiogenesis.
- To elucidate the mechanism by which PAF stimulates MMP-9 expression and activity.
Main Methods:
- Utilized ECV304 cells to assess mRNA expression, protein synthesis, and MMP-9 activity.
- Employed reporter gene assays with MMP-9 promoter and NF-kappaB subunits (p65, p50).
- Investigated the effects of inhibitors (WEB2107, MMP-9, and NF-kappaB inhibitors) in vitro and in vivo (mouse Matrigel implantation model).
Main Results:
- PAF significantly increased MMP-9 mRNA, protein synthesis, and activity in ECV304 cells via NF-kappaB activation.
- PAF elevated MMP-9 promoter activity, which was suppressed by WEB2107 and NF-kappaB inhibitors.
- NF-kappaB subunits (p65/p50) transfection enhanced MMP-9 promoter activity and mRNA expression.
- Inhibition of MMP-9 or NF-kappaB significantly reduced PAF-induced angiogenesis in vivo and endothelial cell sprouting in vitro.
Conclusions:
- NF-kappaB-dependent MMP-9 plays a critical role in mediating Platelet-Activating Factor (PAF)-induced angiogenesis.
- Targeting the NF-kappaB/MMP-9 pathway may offer therapeutic strategies for angiogenesis-related conditions.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Role of Matrix Metalloproteases in Degradation of ECM
A...
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

